{"_links": {"parentPackage": {"href": "/mdr/ct/packages/sdtmct-2017-03-31", "title": "SDTM Controlled Terminology Package 29 Effective 2017-03-31", "type": "Terminology"}, "priorVersion": {"href": "/mdr/ct/packages/sdtmct-2016-12-16/codelists/C120521", "title": "CDISC SDTM Anti-Viral Outcome of Treatment Terminology", "type": "Code List"}, "rootItem": {"href": "/mdr/root/ct/sdtmct/codelists/C120521", "title": "Version-agnostic anchor resource for codelist C120521", "type": "Root Value Domain"}, "self": {"href": "/mdr/ct/packages/sdtmct-2017-03-31/codelists/C120521", "title": "CDISC SDTM Anti-Viral Outcome of Treatment Terminology", "type": "Code List"}}, "conceptId": "C120521", "definition": "A terminology codelist to describe the anti-viral outcome of treatment.", "extensible": "true", "name": "Anti-Viral Outcome of Treatment", "preferredTerm": "CDISC SDTM Anti-Viral Outcome of Treatment Terminology", "submissionValue": "AVOUTTRT", "synonyms": ["Anti-Viral Outcome of Treatment"], "terms": [{"conceptId": "C120597", "definition": "A finding of aviremia at a specified timepoint, early during the treatment period.", "preferredTerm": "Rapid Virologic Response", "submissionValue": "RAPID VIROLOGIC RESPONSE", "synonyms": ["RVR"]}, {"conceptId": "C120598", "definition": "A finding of aviremia at a predetermined time point after the end of planned or actual treatment.", "preferredTerm": "Sustained Virologic Response", "submissionValue": "SUSTAINED VIROLOGIC RESPONSE", "synonyms": ["SVR"]}, {"conceptId": "C120599", "definition": "The subject becomes viremic during the treatment period after a period of treatment-induced aviremia or has an increase in viral load from nadir above a predetermined threshold during the treatment period.", "preferredTerm": "Viral Breakthrough", "submissionValue": "VIRAL BREAKTHROUGH", "synonyms": ["VBT"]}, {"conceptId": "C120600", "definition": "A recurrence of the same virus after a finding of aviremia at the end of planned or actual treatment.", "preferredTerm": "Viral Relapse", "submissionValue": "VIRAL RELAPSE"}, {"conceptId": "C120601", "definition": "A finding of aviremia at the end of the planned or actual end of treatment period.", "preferredTerm": "Virologic End Of Treatment Response", "submissionValue": "VIROLOGIC END OF TREATMENT RESPONSE"}, {"conceptId": "C120602", "definition": "A finding of viremia at or after end of planned or actual treatment, excluding treatment discontinuations for non-virologic reasons.", "preferredTerm": "Virologic Failure", "submissionValue": "VIROLOGIC FAILURE"}, {"conceptId": "C120603", "definition": "The subject remains viremic during the treatment period.", "preferredTerm": "Virologic Non-Response", "submissionValue": "VIROLOGIC NON-RESPONSE"}, {"conceptId": "C120604", "definition": "The subject remains viremic during the treatment period and the decrease in viral load from baseline at a specified timepoint is below or equal to a predetermined threshold.", "preferredTerm": "Virologic Null-Response", "submissionValue": "VIROLOGIC NULL-RESPONSE"}, {"conceptId": "C120605", "definition": "The subject remains viremic during the treatment period and the decrease in viral load from baseline at a specified timepoint is above a predetermined threshold.", "preferredTerm": "Virologic Partial Response", "submissionValue": "VIROLOGIC PARTIAL RESPONSE"}]}